Oxford Pharmascience scouts marketing partners for new pain meds

Oxford Pharmascience is hunting for a marketing partner for two new pain drugs. The U.K.-based pharma started contacting big drugmakers last fall, and has now hired consultants to pursue a deal on OXPzero Ibuprofen and OXPzero Naproxen. The new meds are reformulations of the two common pain relievers, tweaked to taste better and minimize digestive upset. Release

Suggested Articles

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.

Bristol Myers Squibb and Exelixis will soon know whether their I-O/TKI combo gets a chance to challenge Merck and Pfizer's Keytruda-Inlyta regimen.